Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Have any thoughts about
Dallah Healthcare Company SJSC?
Write Note

Dallah Healthcare Company SJSC
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dallah Healthcare Company SJSC
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Dallah Healthcare Company SJSC
SAU:4004
Cash & Cash Equivalents
ď·Ľ143m
CAGR 3-Years
-9%
CAGR 5-Years
2%
CAGR 10-Years
5%
National Medical Care Company JSC
SAU:4005
Cash & Cash Equivalents
ď·Ľ379.5m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
31%
Mouwasat Medical Services Company SJSC
SAU:4002
Cash & Cash Equivalents
ď·Ľ170.6m
CAGR 3-Years
16%
CAGR 5-Years
1%
CAGR 10-Years
3%
A
Al Hammadi Holding Co
SAU:4007
Cash & Cash Equivalents
ď·Ľ350m
CAGR 3-Years
60%
CAGR 5-Years
53%
CAGR 10-Years
26%
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Cash & Cash Equivalents
ď·Ľ537.6m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
D
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Cash & Cash Equivalents
ď·Ľ214.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dallah Healthcare Company SJSC
Glance View

Market Cap
15.8B SAR
Industry
Health Care

Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Intrinsic Value
116.29 SAR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Dallah Healthcare Company SJSC's Cash & Cash Equivalents?
Cash & Cash Equivalents
143m SAR

Based on the financial report for Jun 30, 2024, Dallah Healthcare Company SJSC's Cash & Cash Equivalents amounts to 143m SAR.

What is Dallah Healthcare Company SJSC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%

Over the last year, the Cash & Cash Equivalents growth was -40%. The average annual Cash & Cash Equivalents growth rates for Dallah Healthcare Company SJSC have been -9% over the past three years , 2% over the past five years , and 5% over the past ten years .

Back to Top